Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.

被引：2
|
作者：
Kuboki, Yasutoshi
Kawazoe, Akihito
Komatsu, Yoshito
Nishina, Tomohiro
Shinozaki, Eiji
Hara, Hiroki
Yuki, Satoshi
Fukutani, Miki
Tsukahara, Natsuko
Hasegawa, Hiromi
Hirano, Nami
Nomura, Shogo
Togashi, Yosuke
Nishikawa, Hiroyoshi
Sato, Akihiro
Ohtsu, Atsushi
Yoshino, Takayuki
机构：
[1] Natl Canc Ctr Hosp, Dept Gastrointestinal Oncol, Chiba, Japan
[2] Natl Canc Ctr Hosp, Dept Gastrointestinal Med Oncol, Chiba, Japan
[3] Hokkaido Univ Hosp, Dept Canc Chemotherapy, Sapporo, Hokkaido, Japan
[4] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan
[5] Japanese Fdn Canc Res, Dept Gastroenterol, Canc Inst Hosp, Tokyo, Japan
[6] Saitama Canc Ctr Hosp, Dept Gastroenterol, Saitama, Japan
[7] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
[8] Natl Canc Ctr Hosp East, Off Clin Res Support, Kashiwa, Chiba, Japan
[9] Natl Canc Ctr, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[10] Natl Canc Ctr Hosp, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS3623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3623
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.
    Shinozaki, Eiji
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Komatsu, Yoshito
    Nishina, Tomohiro
    Hara, Hiroki
    Yuki, Satoshi
    Shitara, Kohei
    Bando, Hideaki
    Kotani, Daisuke
    Takahashi, Koji
    Mikamoto, Yuichi
    Hasegawa, Hiromi
    Hirano, Nami
    Nomura, Shogo
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Sato, Akihiro
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Komatsu, Yoshito
    Nishina, Tomohiro
    Shinozaki, Eiji
    Hara, Hiroki
    Yuki, Satoshi
    Shitara, Kohei
    Bando, Hideaki
    Takahashi, Koji
    Mikamoto, Yuichi
    Hasegawa, Hiromi
    Hirano, Nami
    Nomura, Shogo
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Sato, Akihiro
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Scoop: Multicenter phase I/II trial of BBI608 and pembrolizumab in patients with metastatic colorectal cancer (EPOC1503)
    Hara, Hiroki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Komatsu, Yoshito
    Nishina, Tomohiro
    Shinozaki, Eiji
    Yuki, Satoshi
    Takahashi, Koji
    Mikamoto, Yuichi
    Hirano, Nami
    Nomura, Shogo
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Sato, Akihiro
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial)
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Shinozaki, Eiji
    Hara, Hiroki
    Nishina, Tomohiro
    Komatsu, Yoshito
    Yuki, Satoshi
    Wakabayashi, Masashi
    Nomura, Shogo
    Sato, Akihiro
    Kuwata, Takeshi
    Kawazu, Masahito
    Mano, Hiroyuki
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Yoshino, Takayuki
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5887 - 5894
  • [5] A phase Ib study of BBI608 in combination with FOLFIRI with and without bevacizumab in patients (pts) with advanced colorectal cancer (CRC)
    Hubbard, Joleen Marie
    Jonker, Derek J.
    O'Neil, Bert H.
    Halfdanarson, Thorvardur Ragnar
    Grothey, Axel
    Li, Youzhi
    Borodyansky, Laura
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
    Vo, Henry Hiep
    Cartwright, Carrie
    Song, I-Wen
    Karp, Daniel D.
    Nogueras Gonzalez, Graciela M.
    Xie, Yuran
    Karol, Michael
    Hitron, Matthew
    Vining, David
    Tsimberidou, Apostolia-Maria
    CANCERS, 2022, 14 (05)
  • [7] BBI608-201GBM: A phase Ib/II clinical study of napabucasin (BBI608) in combination with temozolomide (TMZ) for adult patients with recurrent glioblastoma (GBM).
    Mason, Warren P.
    de Robles, Paula
    Borodyansky, Laura
    Hitron, Matthew
    Ortuzar, Waldo Feliu
    Khan, Waheed
    Xu, Bo
    Li, Wei
    Li, Youzhi
    Li, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.
    Bekaii-Saab, Tanios S.
    Mikhail, Sameh
    Langleben, Adrian
    Becerra, Carlos
    Jonker, Derek J.
    Asmis, Timothy R.
    Cote, Gregory Michael
    Wu, Christina Sing-Ying
    Kwak, Eunice Lee
    Spira, Alexander I.
    Braiteh, Fadi S.
    Richey, Stephen Lane
    Hume, Stephanie
    Hitron, Matthew
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] BBI608-503-103HCC: A phase Ib/II clinical study of napabucasin (BBI608) in combination with sorafenib or amcasertib (BBI503) in combination with sorafenib (Sor) in adult patients with hepatocellular carcinoma (HCC).
    El-Rayes, Bassel F.
    Richards, Donald A.
    Cohn, Allen Lee
    Richey, Stephen Lane
    Feinstein, Trevor
    Kundranda, Madappa N.
    El-Khoueiry, Anthony B.
    Melear, Jason M.
    Braiteh, Fadi S.
    Hitron, Matthew
    Ortuzar, Waldo Feliu
    Khan, Waheed
    Xu, Bo
    Li, Wei
    Li, Youzhi
    Li, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] BBI608-224: A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) administered with panitumumab in KRAS wild-type patients with metastatic colorectal cancer
    Larson, Tim
    Ortuzar, Waldo Feliu
    Bekaii-Saab, Tanios S.
    Becerra, Carlos
    Ciombor, Kristen Keon
    Hubbard, Joleen Marie
    Edenfield, William Jeffery
    Shao, Spencer H.
    Grothey, Axel
    Borodyansky, Laura
    Xu, Bo
    Li, Wei
    Li, Youzhi
    Li, Chiang
    Khan, Waheed
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345